Splenic thrombosis in three patients with moderate hyperhomocysteinemia, low folate and the C677T variant of the methylenetetrahydrofolate reductase (MTHFR) gene

Thrombosis and Haemostasis

Volumn 94, Issue 6, 2005, Pages 1333-1334

  Starakis, Ioannis ^a   Mougiou, Athina ^a   Leonidou, Lydia ^a   Dimitrios, Siagris ^a   Karatza, Chrysoula ^a  

^a UNIVERSITY HOSPITAL OF PATRAS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ANTICOAGULANT AGENT; FOLIC ACID; HEMOGLOBIN; HEPARIN;

ACUTE HEART INFARCTION; ADULT; ANAMNESIS; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; DEATH; DISEASE SEVERITY; ECHOGRAPHY; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HYPERHOMOCYSTEINEMIA; LEUKOCYTE COUNT; PHYSICAL EXAMINATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SPLEEN DISEASE; SPLENECTOMY; SPLENOMEGALY; THROMBOCYTE COUNT; THROMBOSIS; VEIN OCCLUSION;

EID: 29244438784     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH05-06-1333     Document Type: Article

References (13)

1. Andres E, Pflumio F, Knab MC et al. Splenic thrombosis and celiac disease: a fortuitous association? Presse Med 2000; 29: 1933-4.
2. den Heijer M, Koster T, Blom HJ et al. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 1996; 334: 759-62.
3. Selhub J, Jacques PF, Wilson PW et al. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993; 270: 2693.
4. Ubbink JR, Vermaak WJ, van der Merwe A et al. Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia. Am J Clin Nutr 1993; 57: 47.
5. Durand P, Prost M, Blache D. Pro-thrombotic effects of a folic acid deficient diet in rat platelets and macrophages related to elevated homocysteine and decreased n-3 polyunsaturated fatty acids. Atherosclerosis 1996; 121:231-43.
6. Klerk M, Verhoef P, Clarke R et al. MTHFR 677C->T polymorphism and risk of coronary heart disease: A Meta-analysis. JAMA 2002; 288: 2023.
7. Salomon O, Steinberg DM, Zivelin A et al. Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism. Arterioscler Thromb Vasc Biol 1999; 19: 511-8.
8. 677Val in the methylenetetrahydrofolate reductase gene: a risk factor for arterial disease and venous thrombosis. Thromb Haemost 1997; 77: 818-21.
9. Kluijtmans LAJ, den Heijer M, Reitsma PH et al. Thermolabile methylenetetrahydrofolate reductase and factor V Leiden in the risk of deep vein thrombosis. Thromb Haemost 1998; 79: 254-8.
10. Gemmati D, Serino ML, Trivellato C et al. C677T substitution in the methylenetetrahydrofolate reductase gene as a risk factor for venous thrombosis and arterial disease in selected patients. Haematologica 1999; 84: 824-8.
11. Guttormsen AB, Ueland PM, Nesthus I et al. Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia (40 βmol/liter). The Hordaland homocysteine study. J Clin Invest 1996; 98: 2174-83.
12. Malinow MR, Nieto FJ, Kruger WD et al. The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase genotypes. Arterioscler Thromb Vasc Biol 1997; 17: 1157-62.
13. Kang S-S, Zhou J, Wong PWK et al. Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase. Am J Hum Genet 1988;43: 414-21.